Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in IntangiblesChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesSales of Property, Plant and EquipmentSales of Property, Plant and EquipmentShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Arcadia Biosciences (RKDA) Capital Expenditures (2016 - 2024)

Arcadia Biosciences' Capital Expenditures history spans 11 years, with the latest figure at $3000.0 for Q2 2024.

  • For Q2 2024, Capital Expenditures fell 40.0% year-over-year to $3000.0; the TTM value through Mar 2025 reached $3000.0, down 83.33%, while the annual FY2024 figure was $16000.0, 220.0% up from the prior year.
  • Capital Expenditures reached $3000.0 in Q2 2024 per RKDA's latest filing, down from $13000.0 in the prior quarter.
  • In the past five years, Capital Expenditures ranged from a high of $971000.0 in Q2 2020 to a low of -$2.0 million in Q4 2020.
  • Average Capital Expenditures over 5 years is $83642.9, with a median of $64000.0 recorded in 2021.
  • The largest YoY upside for Capital Expenditures was 5884.62% in 2020 against a maximum downside of 39240.0% in 2020.
  • A 5-year view of Capital Expenditures shows it stood at -$2.0 million in 2020, then skyrocketed by 104.47% to $88000.0 in 2021, then crashed by 70.45% to $26000.0 in 2022, then plummeted by 80.77% to $5000.0 in 2023, then tumbled by 40.0% to $3000.0 in 2024.
  • Per Business Quant, the three most recent readings for RKDA's Capital Expenditures are $3000.0 (Q2 2024), $13000.0 (Q1 2024), and $5000.0 (Q2 2023).